GW regains US rights to Sativex
admin 14th December 2017 Uncategorised 0GW Pharmaceuticals has reacquired full ownership of US rights to its cannabinoid medicine Sativex following the termination of a previous license agreement with Otsuka.
More: GW regains US rights to Sativex
Source: News